Kejia Lu

514 total citations
17 papers, 378 citations indexed

About

Kejia Lu is a scholar working on Epidemiology, Genetics and Infectious Diseases. According to data from OpenAlex, Kejia Lu has authored 17 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 7 papers in Genetics and 4 papers in Infectious Diseases. Recurrent topics in Kejia Lu's work include Virology and Viral Diseases (9 papers), Virus-based gene therapy research (7 papers) and Alzheimer's disease research and treatments (4 papers). Kejia Lu is often cited by papers focused on Virology and Viral Diseases (9 papers), Virus-based gene therapy research (7 papers) and Alzheimer's disease research and treatments (4 papers). Kejia Lu collaborates with scholars based in China, Hong Kong and United States. Kejia Lu's co-authors include Min Li, Ju‐Xian Song, Shaoyang Cui, Nenggui Xu, Xifei Yang, Yimin Jiang, Wenjia Lin, Xiaoyan Zheng, Wenjing Wei and Qingwei Huo and has published in prestigious journals such as Signal Transduction and Targeted Therapy, Autophagy and Poultry Science.

In The Last Decade

Kejia Lu

15 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kejia Lu China 10 132 117 71 63 53 17 378
Mackenzie M. Shipley United States 9 249 1.9× 136 1.2× 95 1.3× 55 0.9× 30 0.6× 14 612
Kin Ki Jim Netherlands 13 176 1.3× 106 0.9× 54 0.8× 42 0.7× 18 0.3× 20 514
Yonggang Zhao China 15 159 1.2× 67 0.6× 38 0.5× 28 0.4× 27 0.5× 33 600
Yongxin Luan China 12 195 1.5× 61 0.5× 88 1.2× 18 0.3× 44 0.8× 17 430
Rongze Wang China 12 200 1.5× 44 0.4× 58 0.8× 28 0.4× 29 0.5× 29 382
Jérôme Boué France 14 226 1.7× 55 0.5× 193 2.7× 61 1.0× 22 0.4× 15 658
Giorgia Napoletani Italy 8 130 1.0× 171 1.5× 128 1.8× 33 0.5× 13 0.2× 9 479
Maren L. Smith United States 13 247 1.9× 43 0.4× 77 1.1× 40 0.6× 14 0.3× 23 424
M. Cecilia López United States 16 355 2.7× 90 0.8× 41 0.6× 67 1.1× 21 0.4× 19 668
Begüm Aydın United States 10 475 3.6× 64 0.5× 118 1.7× 54 0.9× 54 1.0× 12 683

Countries citing papers authored by Kejia Lu

Since Specialization
Citations

This map shows the geographic impact of Kejia Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kejia Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kejia Lu more than expected).

Fields of papers citing papers by Kejia Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kejia Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kejia Lu. The network helps show where Kejia Lu may publish in the future.

Co-authorship network of co-authors of Kejia Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Kejia Lu. A scholar is included among the top collaborators of Kejia Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kejia Lu. Kejia Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Xi, Wei, et al.. (2025). Genetic analyses and functional validation of ruminant SLAMs reveal potential hosts for PPRV. Veterinary Research. 56(1). 57–57.
2.
Guan, Xinjie, Jia Liu, Cheng-Fu Su, et al.. (2024). Corynoxine promotes TFEB/TFE3-mediated autophagy and alleviates Aβ pathology in Alzheimer’s disease models. Acta Pharmacologica Sinica. 45(5). 900–913. 20 indexed citations
3.
Iyaswamy, Ashok, Xueli Wang, Hailong Zhang, et al.. (2024). Molecular engineering of a theranostic molecule that detects Aβ plaques, inhibits Iowa and Dutch mutation Aβ self-aggregation and promotes lysosomal biogenesis for Alzheimer's disease. Journal of Materials Chemistry B. 12(31). 7543–7556. 7 indexed citations
4.
5.
6.
Dong, Xiaoyu, Kejia Lu, Xi Chen, et al.. (2023). Antigenic variation in hemagglutinin-neuraminidase of Newcastle disease virus isolated from Tibet, China. Veterinary Microbiology. 285. 109872–109872. 4 indexed citations
7.
Iyaswamy, Ashok, Kejia Lu, Xinjie Guan, et al.. (2023). Impact and Advances in the Role of Bacterial Extracellular Vesicles in Neurodegenerative Disease and Its Therapeutics. Biomedicines. 11(7). 2056–2056. 15 indexed citations
8.
Krishnamoorthi, Senthilkumar, Ashok Iyaswamy, Sravan Gopalkrishnashetty Sreenivasmurthy, et al.. (2023). PPARɑ Ligand Caudatin Improves Cognitive Functions and Mitigates Alzheimer’s Disease Defects By Inducing Autophagy in Mice Models. Journal of Neuroimmune Pharmacology. 18(3). 509–528. 11 indexed citations
9.
Iyaswamy, Ashok, Abhimanyu Thakur, Xinjie Guan, et al.. (2023). Fe65-engineered neuronal exosomes encapsulating corynoxine-B ameliorate cognition and pathology of Alzheimer’s disease. Signal Transduction and Targeted Therapy. 8(1). 404–404. 77 indexed citations
10.
Yang, Mengqing, Jian‐Gang Ma, Zhili Chu, et al.. (2021). Musashi1 inhibit the release of Newcastle disease viruses through preventing apoptosis of DF-1 cells. Poultry Science. 100(7). 101105–101105. 6 indexed citations
11.
Liu, Haijin, Kejia Lu, Yangyang Li, et al.. (2021). Chicken ISG12(2) attenuates Newcastle disease virus and enhances the efficiency of Newcastle disease vaccine via activating immune pathways. Transboundary and Emerging Diseases. 69(5). 2634–2648. 6 indexed citations
12.
13.
Chu, Zhili, Xiaolong Gao, Haijin Liu, et al.. (2019). Newcastle disease virus selectively infects dividing cells and promotes viral proliferation. Veterinary Research. 50(1). 27–27. 13 indexed citations
14.
Chu, Zhili, Caiying Wang, Xiaolei Shi, et al.. (2018). Newcastle Disease Virus V Protein Inhibits Cell Apoptosis and Promotes Viral Replication by Targeting CacyBP/SIP. Frontiers in Cellular and Infection Microbiology. 8. 304–304. 34 indexed citations
15.
Wang, Caiying, Zhili Chu, Wenkai Liu, et al.. (2018). Newcastle disease virus V protein inhibits apoptosis in DF-1 cells by downregulating TXNL1. Veterinary Research. 49(1). 102–102. 24 indexed citations
16.
Chu, Zhili, Jian‐Gang Ma, Caiying Wang, et al.. (2018). Newcastle Disease Virus V Protein Promotes Viral Replication in HeLa Cells through the Activation of MEK/ERK Signaling. Viruses. 10(9). 489–489. 16 indexed citations
17.
Cran, D. G., et al.. (1994). Separation of X- and Y-chromosome bearing bovine sperm by flow cytometry for use in IVF. Theriogenology. 41(1). 183–183. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mackenzie M. Shipley Breakdown of academic impact, for papers by Kin Ki Jim Breakdown of academic impact, for papers by Yonggang Zhao Breakdown of academic impact, for papers by Yongxin Luan Breakdown of academic impact, for papers by Rongze Wang Breakdown of academic impact, for papers by Jérôme Boué Breakdown of academic impact, for papers by Giorgia Napoletani Breakdown of academic impact, for papers by Maren L. Smith Breakdown of academic impact, for papers by M. Cecilia López Breakdown of academic impact, for papers by Begüm Aydın
Rankless by CCL
2026